Haemonetics ( NYSE: HAE ) is scheduled to announce Q1 earnings results on Thursday, August 8th, before market open. The consensus EPS Estimate is $1.01 (-3.
8% Y/Y) and the consensus Revenue Estimate is $335.04M (+7.6% Y/Y).
Over the last 2 years, HAE has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time. Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 4 upward revisions and 1 downward.
More on Haemonetics Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript Haemonetics prices its senior notes offering Seeking Alpha’s Quant Rating on Haemonetics Historical earnings data for Haemonetics.
